Finzati - Logo
CVAC logo

CureVac N.V.

CVACBiotechnology
$4.66
0.00 (0.00%)
Current price
EarningsLatest report: Nov 24, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.05B
Growth
78.7%
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 30.3%Positive revenue growth · 59.4%Positive free cash flow · 0.37Reasonable earnings multiple · 4.56Manageable debt level · 0.06
Financial data as of: Nov 24, 2025, 12:00 AM UTCLast earnings update: Nov 24, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$4.66
Change0.00%
Shares Out225.17M
Market Cap$1.05B
52W Range2.48 - 5.72
Beta1.84
P/E0.95
P/S19.10
P/B1.19
P/FCF35.01
EV/Sales12.06
EV/EBITDA2.05

Investment DNA

How strong this company looks for long-term investors

75
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score
Stable or improving margins · 30.3%Positive revenue growth · 59.4%Positive free cash flow · 0.37Reasonable earnings multiple · 4.56Manageable debt level · 0.06Healthy liquidity · 7.28

Analyst view

Analyst sentiment and price target

CVAC
Analyst sentiment
Based on 8 analyst votes · 2026-09-04
56/100
Neutral
Bullish
2
Hold
5
Bearish
1
Price Target
2026-06-06
Low
$5.00
Mean
$21.00
Median
$21.00
High
$37.00

Company Overview

IPO: 8/14/2020
Industry: Biotechnology
P/B i: 1.19
Debt / Equity i: 0.06
Operating Margin: 33.20%
Net Margin: 30.30%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.06
Current Ratio: 7.28
Quick Ratio: 7.27
Status: Good
🧾

No insider activity

No recent insider transactions available.